Siemens Healthineers AG SHL

Both companies are years from commercial scale and burning cash to get there. The difference is in how long each can keep going.

Opportunities center on automated, standardized TDM kits integrated with AI dosing tools for antimicrobial stewardship, transplant care and precision medicine, especially in Asia-Pacific.Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "TDM Reagent Kit Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. This market research report examines the global TDM Reagent Kit Market, projected to reach USD 2.87 billion in 2026 and grow at a CAGR of 15.84% to USD 6.96 billion

Siemens Healthineers (XTRA:SHL) and Novo announced a new collaboration to address MASLD and MASH using non-invasive diagnostics. The partnership focuses on expanding disease awareness and clinical use of less invasive tools for assessing liver health and progression risk. Both groups aim to support earlier identification of at-risk patients, potentially affecting how metabolic liver conditions are managed in routine care. The Siemens Healthineers and Novo MASLD and MASH collaboration is...

Personalized medicine and chronic disease care are driving demand for TDM, with opportunities in consumables, automation, point-of-care devices, AI software and pharmacogenomics.Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Therapeutic Drug Monitoring - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Therapeutic Drug Monitoring was estimated at US$1.5 Billion in 2025 and is projected to reach US$2.6 Billion by 2032, growing at a CAGR of 8

Tarrytown, New York, USA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- People most at risk for MASLD/MASH remain largely unaware of the disease and its wider health risksPatients facing this metabolic condition benefit from early interventionThe companies aim to remove barriers to non-invasive testing Siemens Healthineers and Novo have announced a collaboration focused on advancing care for people living with metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabo

The global theranostics market is set for significant growth through 2036, driven by precision medicine, rising cancer prevalence, molecular imaging advances and targeted radiopharmaceutical therapies. Oncology leads adoption, while therapeutic agents and radiotheranostics are key growth segments. North America holds the largest market share, with Asia-Pacific forecast to grow fastest. The report analyses market trends, technologies, applications, regional opportunities and leading companies, in

The global smart hospital market is projected to grow from USD 134.69 billion in 2026 to USD 246.17 billion by 2032, registering a 10.6% CAGR. Growth is driven by AI-enabled healthcare, IoMT, cloud computing, robotics, connected medical devices, remote patient monitoring and digital health platforms. Cloud-based deployment will lead the market, while Wi-Fi remains a key connectivity technology. Asia Pacific is forecast to be the fastest-growing region. Leading players include Siemens Healthineer

The global point-of-care diagnostics market is projected to grow from USD 20.63 billion in 2026 to USD 31.46 billion by 2031, at an 8.8% CAGR. Growth is driven by demand for rapid, accurate and decentralized testing, alongside advances in molecular diagnostics, microfluidics, multiplex assays and portable analyzers. Biochemistry holds the largest technology share, while molecular diagnostics and infectious disease testing are set for strong growth. Clinical laboratories lead by end user, and Nor

Delray Beach, FL, Sept. 09, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global MRI systems market will grow from USD 6.88 billion in 2026 to USD 9.68 billion by 2031, at a CAGR of 7.0% during the forecast period. Market growth is fueled by the increasing prevalence of neurological and musculoskeletal disorders, expanding geriatric population, growing incidence of chronic diseases such as cancer, increasing awareness regarding preventive healthcare, and regulatory support for innovat

150-Page Report Forecasts Market Growth from $8.50B (2025) to $18.50B by 2034, Profiling Roche, Abbott, Siemens Healthineers, Thermo Fisher, Labcorp, and 5 Other Key PlayersDublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The "Blood Based Biomarkers - Market Insights, Competitive Landscape, and Market Forecast - 2034" has been added to ResearchAndMarkets.com's offering. Blood Based Biomarkers Market Projected to Reach USD 18.50 Billion by 2034 The global blood based biomarkers market is estimated at U

Report Features In-Depth Profiles of Abbott, Great Robotics, Intuitive Surgical, Johnson & Johnson, Medtronic, Panasonic, Renishaw, Siemens Healthineers, Smith+Nephew, Stryker, Zimmer Biomet, and FreehandDublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Surgical Robots Market by Offering of Surgical Robot Developers, Deployment Model, Type of Surgical Procedure Supported, Application Area, End Users and Key Geographical Regions - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.

IORT demand is rising as single-session care eases capacity constraints. Portable, AI-enabled systems, brachytherapy and turnkey services offer opportunities in underserved regions.Dublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The "Intraoperative Radiation Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The global intraoperative radiation therapy market is estimated at USD 132.93 million in 2026, up fr

Opportunities center on portable cardiac ultrasound, AI-assisted imaging, 3D/Doppler tools, cloud-enabled remote diagnostics and early, noninvasive screening Cardiovascular Ultrasound System Market Cardiovascular Ultrasound System Market Dublin, Sept. 02, 2026 (GLOBE NEWSWIRE) -- The "Cardiovascular Ultrasound System Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global cardiovascular ultrasound system market is experiencing strong growth, supported by the rising pr

Delays occurring before patients reach stroke centers remain a major barrier to timely treatment across Southeast Asia, according to a new report, Strengthening Stroke System Readiness Across ASEAN, unveiled today by Siemens Healthineers at Hospital Management Asia (HMA) 2026 in Bangkok, Thailand.

At this year's Hospital Management Asia (HMA) healthcare conference, Siemens Healthineers is showcasing how artificial intelligence (AI), data and innovative technologies can transform care delivery by creating more connected pathways. HMA 2026 takes place in Bangkok, Thailand, from September 1-4.

BOSTON, August 27, 2026--Carna Health, an AI-enabled digital health company revolutionizing Cardio-Kidney-Metabolic (CKM) care, today announced several strategic leadership appointments, including the addition of multidisciplinary healthcare and technology experts as strategic advisors. The appointments bring expertise across AI, business development, technology, and public health to support the company’s continued growth and global expansion, building on strategic partnerships with Siemens Heal

Building on its image-guided therapy platform, Philips will work with academic collaborators to create a robot capable of performing mechanical thrombectomies autonomously.

Accelerating clinical adoption highlighted by GE HealthCare’s latest FDA clearance for AI-guided radiation planning, Canon Medical’s AI deep-learning CT launch, and strong 2026 order books across Siemens Healthineers and Philips is transforming diagnostic workflows globally. This study delivers an in-depth competitive analysis, technology roadmap, and regional forecasts across MRI, CT, X-ray, Ultrasound, and PET modalities. AI-Enabled Imaging Modalities Market AI-Enabled Imaging Modalities Marke